Biopharmaceutical study of the hepato-biliary transport of drugs. VII. Improvement of the bioavailability of rifampicin by dosage form design.
D000818:Animals; D001646:Bile / Q000378:metabolism*; D001682:Biological Availability; D004285:Dogs; D004304:Dosage Forms; D008055:Lipids; D014677:Pharmaceutical Vehicles; D051381:Rats; D012293:Rifampin / Q000378:metabolism*
D004304:Dosage Forms; D008055:Lipids; D014677:Pharmaceutical Vehicles; D012293:Rifampin